Comparative Effectiveness of Ustekinumab Versus Adalimumab in Induction of Clinical Response and Remission in Crohn's Disease: Experience of a Real-World Cohort at a Tertiary Care Inflammatory Bowel Disease Referral Center.

Ahmed, Zunirah; Venkata, Krishna; Zhang, Nan; Malik, Talha A

Ahmed, Zunirah; Venkata, Krishna; Zhang, Nan; Malik, Talha A.

Afiliação

Ahmed Z; Department of Medicine, University of Alabama at Birmingham, Montgomery, AL 36116, USA.
Venkata K; Hospitalist Medicine, Baptist South, Montgomery, AL 36116, USA.
Zhang N; Department of Biostatistics, Mayo Clinic, Scottsdale, AZ 85260, USA.
Malik TA; Department of Medicine-Gastroenterology, Mayo Clinic, Scottsdale, AZ 85260, USA.

Gastroenterology Res ; 12(5): 245-251, 2019 Oct.

Article em En | MEDLINE | ID: mdl-31636774

Palavras-chave

Adalimumab; Clinical remission; Clinical response; Crohn's disease; Efficacy; TNF-experienced; TNF-naive; Ustekinumab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Revista: Gastroenterology Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Canadá

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google